NCT00002080View on ClinicalTrials.gov

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Mycobacterium Avium-intracellulare InfectionHIV Infections
Interventions
DRUG

Rifabutin

Trial Locations (1)

19087

PACT, Saint Davids

Sponsors

Lead Sponsor

Pharmacia
All Listed Sponsors
lead

Pharmacia

INDUSTRY

NCT00002080 - Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study | Biotech Hunter | Biotech Hunter